Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2023-11, Vol.24 (23)
1. Verfasser:	Lymperopoulos, Anastasios
Format:	Artikel
Sprache:	eng
Schlagworte:	Carfilzomib Dextrose Diabetes Diabetes therapy Drug therapy Glucose Hypoglycemic agents
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	23
container_start_page
container_title	International journal of molecular sciences
container_volume	24
creator	Lymperopoulos, Anastasios
description
doi_str_mv	10.3390/ijms242316865
format	Article
fullrecord	<record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A775890178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A775890178</galeid><sourcerecordid>A775890178</sourcerecordid><originalsourceid>FETCH-LOGICAL-g678-3b4b42540c98f5a2a0ed26135bde0f7b894c4b526e3b653396c4a2a36844728b3</originalsourceid><addsrcrecordid>eNptjj1PwzAYhD2ARCmM7JaY09qvPyOmqipgVMSQ7pXt2KmrfKA4_H9SwcCAbjjp9NzpEHqgZMVYSdbp3GXgwKjUUlyhBeUABSFS3aDbnM-EAANRLtDTrk7TMCbb4jiMeDoFbMzbe7U2uPoM_pKbnL8CHnpcNe0E2PSn5C6dfIeuo21zuP_1JTo87w7b12L_8WK2m33RSKUL5rjjIDjxpY7CgiWhBkmZcHUgUTldcs-dABmYk2I-Lz2fKSY15wq0Y0v0-DPb2DYcUx-HabS-S9kfN0oJXRKq9Eyt_qFm1aFLfuhDTHP-p_ANmypUsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors</title><source>PubMed (Medline)</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Lymperopoulos, Anastasios</creator><creatorcontrib>Lymperopoulos, Anastasios</creatorcontrib><identifier>ISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms242316865</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Carfilzomib ; Dextrose ; Diabetes ; Diabetes therapy ; Drug therapy ; Glucose ; Hypoglycemic agents</subject><ispartof>International journal of molecular sciences, 2023-11, Vol.24 (23)</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Lymperopoulos, Anastasios</creatorcontrib><title>Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors</title><title>International journal of molecular sciences</title><subject>Carfilzomib</subject><subject>Dextrose</subject><subject>Diabetes</subject><subject>Diabetes therapy</subject><subject>Drug therapy</subject><subject>Glucose</subject><subject>Hypoglycemic agents</subject><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjj1PwzAYhD2ARCmM7JaY09qvPyOmqipgVMSQ7pXt2KmrfKA4_H9SwcCAbjjp9NzpEHqgZMVYSdbp3GXgwKjUUlyhBeUABSFS3aDbnM-EAANRLtDTrk7TMCbb4jiMeDoFbMzbe7U2uPoM_pKbnL8CHnpcNe0E2PSn5C6dfIeuo21zuP_1JTo87w7b12L_8WK2m33RSKUL5rjjIDjxpY7CgiWhBkmZcHUgUTldcs-dABmYk2I-Lz2fKSY15wq0Y0v0-DPb2DYcUx-HabS-S9kfN0oJXRKq9Eyt_qFm1aFLfuhDTHP-p_ANmypUsQ</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Lymperopoulos, Anastasios</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20231101</creationdate><title>Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors</title><author>Lymperopoulos, Anastasios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g678-3b4b42540c98f5a2a0ed26135bde0f7b894c4b526e3b653396c4a2a36844728b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carfilzomib</topic><topic>Dextrose</topic><topic>Diabetes</topic><topic>Diabetes therapy</topic><topic>Drug therapy</topic><topic>Glucose</topic><topic>Hypoglycemic agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lymperopoulos, Anastasios</creatorcontrib><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lymperopoulos, Anastasios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors</atitle><jtitle>International journal of molecular sciences</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>24</volume><issue>23</issue><issn>1422-0067</issn><pub>MDPI AG</pub><doi>10.3390/ijms242316865</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 1422-0067
ispartof	International journal of molecular sciences, 2023-11, Vol.24 (23)
issn	1422-0067
language	eng
recordid	cdi_gale_infotracmisc_A775890178
source	PubMed (Medline); MDPI - Multidisciplinary Digital Publishing Institute; Free E-Journal (出版社公開部分のみ）
subjects	Carfilzomib Dextrose Diabetes Diabetes therapy Drug therapy Glucose Hypoglycemic agents
title	Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T05%3A12%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20for%20the%20IIJMS/I%20Special%20Issue%20on%20Sglt2%20Inhibitors&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Lymperopoulos,%20Anastasios&rft.date=2023-11-01&rft.volume=24&rft.issue=23&rft.issn=1422-0067&rft_id=info:doi/10.3390/ijms242316865&rft_dat=%3Cgale%3EA775890178%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A775890178&rfr_iscdi=true